Targeting DDX3X Helicase Activity with BA103 Shows Promising Therapeutic Effects in Preclinical Glioblastoma Models.
- Resource Type
- Article
- Source
- Cancers; Nov2021, Vol. 13 Issue 21, p5569, 1p
- Subject
ENZYME inhibitors BIOLOGICAL models DRUG efficacy SMALL molecules DRUG tolerance FIBROBLASTS BLOOD-brain barrier XENOGRAFTS IN vivo studies ANIMAL experimentation GLIOMAS CANCER GENE expression CELL motility CELL migration inhibition CELL proliferation DRUG development CELL lines CARRIER proteins EVALUATION - Language
- ISSN
- 20726694